Callio Hires Chris Hassig as Chief Scientific Officer — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Callio Therapeutics hired Chris Hassig as chief scientific officer.
- Chris Hassig previously held the same chief scientific officer role at Boundless Bio.
- Chris Hassig’s appointment is featured in the current installment of STAT+’s regular “Up and down the ladder” series, which highlights a different person each week.
Why it matters: Callio Therapeutics is adding one executive to its scientific leadership: Chris Hassig, whose immediately prior job was the same chief scientific officer post at Boundless Bio. The direct effect is continuity in title and function at the leadership level, rather than a change in rank or a newly described mandate.
Ask SkimNews